High cholesterol diet results in increased expression of interleukin-6 and caspase-1 in the brain of apolipoprotein E knockout and wild type mice
暂无分享,去创建一个
M. Schultzberg | M. Crisby | S. M. A. Rahman | A. -M. Van Dam | M. Schultzberg | M. Crisby | A. Dam | S. Rahman
[1] W. Griffin,et al. Interleukin-1 Promotes Expression and Phosphorylation of Neurofilament and tau Proteins in Vivo , 2000, Experimental Neurology.
[2] K. Blennow,et al. Intrathecal inflammation precedes development of Alzheimer’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.
[3] E. Keller,et al. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. , 2000, Annual review of medicine.
[4] A. Hofman,et al. Pharmacologic agents associated with a preventive effect on Alzheimer's disease: a review of the epidemiologic evidence. , 2002, Epidemiologic reviews.
[5] J. Dietschy,et al. Cholesterol metabolism in the brain , 2001, Current opinion in lipidology.
[6] N. Maeda,et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.
[7] Hee-Yong Kim,et al. A new role for apolipoprotein E: modulating transport of polyunsaturated phospholipid molecular species in synaptic plasma membranes , 2002, Journal of neurochemistry.
[8] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[9] John Calvin Reed,et al. Fundamental role of the Rip2/caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. Barger,et al. Neuronal–Glial Interactions Mediated by Interleukin-1 Enhance Neuronal Acetylcholinesterase Activity and mRNA Expression , 2000, The Journal of Neuroscience.
[11] B. Winblad,et al. Effects of high cholesterol diet on gliosis in apolipoprotein E knockout mice Implications for Alzheimer’s disease and stroke , 2004, Neuroscience Letters.
[12] G. Stoll,et al. Induction of the proinflammatory cytokine interleukin‐18 by axonal injury , 2001, Journal of neuroscience research.
[13] H. Cohen,et al. Cytokines and Cognition—The Case for A Head‐to‐Toe Inflammatory Paradigm , 2002, Journal of the American Geriatrics Society.
[14] C. Colton,et al. Apolipoprotein E isoform mediated regulation of nitric oxide release. , 2002, Free radical biology & medicine.
[15] B. Winblad,et al. Neuronal expression of caspase-1 immunoreactivity in the rat central nervous system , 2004, Journal of Neuroimmunology.
[16] C. Kawas,et al. Immune reactive cells in senile plaques and cognitive decline in Alzheimer’s disease , 2003, Neurobiology of Aging.
[17] A. Hofman,et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. , 2001, The New England journal of medicine.
[18] J. Losy,et al. IL‐18 in patients with multiple sclerosis , 2001, Acta neurologica Scandinavica.
[19] G. Forloni,et al. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. , 1992, Brain research. Molecular brain research.
[20] T. Kishimoto,et al. Gp130 and the interleukin-6 family of cytokines. , 1997, Annual review of immunology.
[21] J W Rowe,et al. Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging , 2002, Neurology.
[22] R. Black,et al. Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. , 1988, The Journal of biological chemistry.
[23] B. Winblad,et al. Statins in the Prevention and Treatment of Alzheimer Disease , 2002, Alzheimer disease and associated disorders.
[24] R. Dantzer,et al. Effects of lipopolysaccharide and glucocorticoids on expression of interleukin-1β converting enzyme in the pituitary and brain of mice , 1996, Journal of Neuroimmunology.
[25] B. Winblad,et al. Immunohistochemical localization of interleukin-1β, interleukin-1 receptor antagonist and interleukin-1β converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid , 1999, Neuroscience.
[26] C. Masters,et al. In‐vitro matured human macrophages express Alzheimer's βA4‐amyloid precursor protein indicating synthesis in microglial cells , 1991, FEBS letters.
[27] Rong Wang,et al. Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model , 2000, Neurobiology of Disease.
[28] G. Forloni,et al. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures , 1995, Neuroscience Letters.
[29] Rodney W. Johnson,et al. Increased interleukin-6 expression by microglia from brain of aged mice , 1999, Journal of Neuroimmunology.
[30] Shai Shaham,et al. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme , 1993, Cell.
[31] K. Iverfeldt,et al. Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576 , 2001, Neuroscience Letters.
[32] P. Mcgeer,et al. Clinically tested drugs for Alzheimer’s disease , 2003, Expert opinion on investigational drugs.
[33] J. Mankovich,et al. Crystal structure of the cysteine protease interleukin-1β-converting enzyme: A (p20/p10)2 homodimer , 1994, Cell.
[34] D. Sparks,et al. Alterations of Alzheimer's Disease in the Cholesterol‐fed Rabbit, Including Vascular Inflammation: Preliminary Observations , 2000, Annals of the New York Academy of Sciences.
[35] J Tuomilehto,et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.
[36] Junying Yuan,et al. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3 , 1993, Cell.
[37] C. Dinarello,et al. Elevated Intracranial IL-18 in Humans and Mice after Traumatic Brain Injury and Evidence of Neuroprotective Effects of IL-18—Binding Protein after Experimental Closed Head Injury , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[38] M. Hüll,et al. Interleukin-6-associated inflammatory processes in Alzheimer's disease: New therapeutic options , 1996, Neurobiology of Aging.
[39] R. Maccioni,et al. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. , 2004, Experimental cell research.
[40] G. Fantuzzi,et al. Response to local inflammation of IL-1 beta-converting enzyme- deficient mice. , 1997, Journal of immunology.
[41] D. Gruol,et al. Physiological and pathological roles of interleukin-6 in the central nervous system , 1997, Molecular Neurobiology.
[42] P. Contreras,et al. Increased Expression of IL-1β Converting Enzyme in Hippocampus after Ischemia: Selective Localization in Microglia , 1996, The Journal of Neuroscience.
[43] Guo-Yuan Yang,et al. Reduced Ischemic Brain Injury in Interleukin-1β Converting Enzyme—Deficient Mice , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[44] H. W. Harris,et al. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[45] T. Golde. Inflammation takes on Alzheimer disease , 2002, Nature Medicine.
[46] M. Hüll. Interleukin-6-Associated Inflammatory Processes in Alzheimer's Disease: New Therapeutic Options , 1996 .
[47] M. Kurimoto,et al. Interferon-γ–inducing factor (IL-18) and interferon-γ in inflammatory CNS diseases , 1999, Neurology.
[48] D. Steinberg,et al. The cholesterol controversy is over. Why did it take so long? , 1989, Circulation.
[49] Richard Mohs,et al. Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease. , 2003, Archives of neurology.
[50] P. Cameron,et al. Identification of a monocyte specific pre-interleukin 1 beta convertase activity. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[51] R. Mrak,et al. Interleukin‐1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer’s disease , 2002, Journal of leukocyte biology.
[52] Mark A. Murcko,et al. Structure and mechanism of interleukin-lβ converting enzyme , 1994, Nature.
[53] N. Maeda,et al. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. , 1994, The Journal of clinical investigation.
[54] C. March,et al. Molecular cloning of the interleukin-1 beta converting enzyme. , 1992, Science.